Blood Res.
2022 Apr;57(S1):S20-S26. 10.5045/br.2022.2022035.
Diagnosis and management of monoclonal gammopathy of clinical significance
- Affiliations
-
- 1Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- KMID: 2529302
- DOI: http://doi.org/10.5045/br.2022.2022035
Abstract
- The term “monoclonal gammopathy of clinical significance” (MGCS) refers to any plasma cell or B-cell clonal disorder that does not meet the current criteria for malignant disorders but produces a monoclonal protein that directly or indirectly results in organ damage. The most commonly affected organs are the kidneys, nerves, and skin. This review summarizes the current classification of MGCS and its diagnostic and treatment approaches.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Monoclonal Gammopathy of Undetermined Significance Presented as a Vasculitic Neuropathy
- A Case of Monoclonal Gammopathy Associated with Aplastic Anemia: Insights into the Etiology and Points to be Considered During Diagnosis
- Generalized Plane Xanthoma Associated with Monoclonal Gammopathy of Unknown Significance
- A Practical Review of Paraproteinemic Neuropathy
- Cryoglobulinemia with a Digital Gangrene from Monoclonal Gammopathy of Undetermined Significance
